Control Bionics (ASX:CBL)

?? Dive into the Future of Assistive Neurotechnology ? Join us at the Sydney Neurotech Meetup for an inspiring evening of conversation and connection with Sydney's leading neurotech startups, researchers, investors and collaborators. ? On 4 December Cameron Higgins, Founder and CEO of Resonait will facilitate a conversation on assistive neurotechnology with?Peter S Ford and?Alistair McEwan. ? ?? Speakers: Peter Shann Ford, Founder of Control Bionics (ASX:CBL) and inventor of the NeuroNode, a groundbreaking device enabling communication and independence for people with ALS, CP, and spinal injuries. Alistair McEwan, Cerebral Palsy Chair of Technology & Engineering at the University of Sydney and co-founder of Sydney Neurobionics Collaboration, driving innovative solutions for people with CP. ? This is your chance to explore how neurotech startups are scaling up, learn from pioneers in the field, and network with the community shaping the future of assistive technology. ? ?? When: Wednesday, 4 December, 6:00 PM ?? Where: Sydney Knowledge Hub ?? RSVP now: https://lnkd.in/gs2KtwEb Rupal Ismin Karla P. Jane Cockburn Nikola Amanovic Cameron Higgins Peter S Ford Alistair McEwan Sydney Knowledge Hub University of Sydney #assistiveneurotechnology #Neurotech #CerebralPalsy ResonaitControl Bionics (ASX:CBL)

Control Bionics Inc has a Sales Consultant Opportunity open! The position is remote based out of either NC, TN or VA. Living in North Carolina is ideal! Apply here: https://lnkd.in/gHADWaFz

Please come by and visit the team Friday to see #DROVE in action!

Happy Occupational Therapist Week! ?? Here’s to all the amazing Occupational Therapists empowering lives through care, creativity, and compassion. ?? Thanks for everything you do ?? #OTWeek #OccupationalTherapy

ATIA’s October 30 webinar unpacks new federal guidance helping to expand access to assistive technology (AT) for children with disabilities. Speakers will share strategies for leveraging this guidance in your work. Register for free at atia.org/webinar

Join us for an interactive event co-hosted by Control Bionics and a panel of experienced speech pathologists working within the NDIS space. Date: 13th of November 2024 at 6-8pm Location: Rooftop at 8 Adolph Street, Cremorne, VIC, 3121 Reserve your spot here: https://lnkd.in/gc7jxybC

Work closely with experienced Occupational Therapists from Better Rehab in an 8 week, part-time research project to assess the world's first autonomous wheelchair module, DROVE. If you would like to learn more, please reach out at [email protected].

Control Bionics boosts revenue with faster NDIS approvals and new leasing program https://buff.ly/47T9rZA #ASX #ASX200 $CBL Control Bionics (ASX:CBL)

We're thrilled to announce a significant increase in revenue thanks to faster NDIS approvals. With $1m in the pipeline, we are confident of continued success with the NDIS after securing ~$400k in approvals over the past 8 weeks. This is more than the previous five months combined. ?? New Launch - Long-term Leasing Program This initiative is for our Trilogy system in Australia, helping those with neurodegenerative conditions access life-changing communication technology faster with a more affordable option. First approvals are in, and we’re excited to roll out this initiative further with our NeuroNode product. ?? Rights Issue Update We're conducting a pro-rata non-renounceable rights issue to raise up to $2.1 million. The rights issue is underwritten for ~$890,000 and will support the commercialisation of the NeuroStrip, the launch of DROVE, and the expansion of the NeuroNode Only strategy. ?? Research and Development Tax Incentive We also recently received a Research and Development Tax Incentive of $736,794 for FY24. The debt facility with Radium Capital has now been repaid leaving a residual amount of $288,587. #NDIS #AssistiveTechnology #Neurotech #ControlBionics #ASXnews #Investment #NeuroNode Jeremy Steele Roger Hawke Joe Durak David Falk Kanak Sahasrabudhe Adi Deshpande

I enjoyed sitting down with Paul Sanger and the team at Finance News Network this week to discuss the strong six months Control Bionics (ASX:CBL) has had. We had the chance to talk about our recent success in the US and Europe and the outlook for FY25. We're looking forward to sharing further news in the coming months. https://lnkd.in/gY4VM_fX